Pfizer Vaccine Wins ApprovalĀ in Italy for Kids Aged 5-11
(Bloomberg) -- Italy's medicines agency Aifa approved the use of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children aged 5-11.
The approval follows that of the European Union's drugs regulator last month. Two shots will be administered at a three-week interval, and the dosage for kids will be a third of that given to adults and adolescents.Ā
READ MORE: Pfizer-BioNTech Covid Shot Wins EU Panel's Backing for Kids
The vaccine has shown a āhigh level of effectiveness and at the moment there are no warning signals in terms of safety,ā Aifa's scientific panel said in a statement on Wednedsay evening. The agency said that the vaccine will allow children to attend school and conduct a normal life, which is particularly important at that age.
Italy is facing a resurgence of cases, which prompted the government to issue new rules that will all but shut out unvaccinated people from leisure activities. Proof of vaccination, recovery or a recent negative test is already required to work, travel and access most indoor venues. Many cities, including Rome and Milan, have also introduced an outdoor mask mandate for crowded areas and city centers.
©2021 Bloomberg L.P.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.